Jonathan Anderman
General Counsel at Compass Therapeutics, Inc. (CMPX) since August 2024
Jonathan Anderman has filed 7 insider reports with the SEC since August 2024, as general Counsel at Compass Therapeutics, Inc. (CMPX). Jonathan Anderman made no open-market purchases or sales in the last 12 months. In the latest amended filing, on April 30, 2026, Jonathan Anderman bought 25,000 shares of Compass Therapeutics, Inc. (CMPX) for $47.3K at an average of $1.89.
- Filings
- 7
- Companies
- 1
- Bought on market
- $30.8K
- Sold on market
- None
Companies where Jonathan Anderman is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| General Counselsince August 2024 | 196,000 | $30.8K | $1.54 | $0.6882-55% | Apr 30, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Apr 29, 2026+$47.3KCMPXAmendment: General Counsel Anderman Jonathan bought $47,250 worth of shares (25,000 units at $1.89), increasing direct ownership by 15% to 196,000 unitsForm 4/AOpen-market purchase
- Apr 29, 2026CMPXGeneral Counsel Anderman Jonathan was granted 25,000 shares, increasing direct ownership by 15% to 196,000 unitsForm 4Grant or award
- Jan 2, 2026CMPXGeneral Counsel Anderman Jonathan was granted 150,000 shares, increasing direct ownership by 714% to 171,000 unitsForm 4Grant or award
- Apr 7, 2025+$30.8KCMPXGen Counsel & Corporate Sec Anderman Jonathan bought $30,800 worth of shares (20,000 units at $1.54), increasing direct ownership by 2,000% to 21,000 unitsForm 4Open-market purchase
- Feb 11, 2025CMPXSEC Form 4 filed by Sr VP, Gen Counsel & Corp Sec Anderman JonathanForm 4Grant or award
- Aug 13, 2024CMPXSEC Form 4 filed by Sr VP, Gen Counsel & Corp Sec Anderman JonathanForm 4Grant or award
- Aug 1, 2024CMPXNew insider Anderman Jonathan claimed ownership of 1,000 sharesForm 3New insider
Compare Jonathan Anderman with
- Jonathan Anderman vs Neil Lerner1 shared
- Jonathan Anderman vs Thomas J. Schuetz1 shared
- Jonathan Anderman vs Barry Shin1 shared
- Jonathan Anderman vs Cynthia Sirard1 shared
- Jonathan Anderman vs Arjun Prasad1 shared
- Jonathan Anderman vs Richard S Lindahl1 shared
Other insiders at the same companies
- Neil LernerCMPX
- Thomas J. SchuetzCMPX
- Barry ShinCMPX
- Cynthia SirardCMPX
- Arjun PrasadCMPX
- Richard S LindahlCMPX
- Ellen ChiniaraCMPX
- Mary Ann GrayCMPX
- James P BoylanCMPX
- Carl L GordonCMPX
- Philip FerneauCMPX
- Orbimed Advisors LLCCMPX
- The Biotech Growth Trust PLCCMPX
Questions about Jonathan Anderman
- What is Jonathan Anderman's role at Compass Therapeutics, Inc.?
- Jonathan Anderman reports to the SEC as general Counsel at Compass Therapeutics, Inc. (CMPX), according to the latest filing on April 30, 2026.
- How many shares does Jonathan Anderman own?
- After the latest filing that states it, Jonathan Anderman directly owned 196,000 shares of Compass Therapeutics, Inc. (CMPX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Jonathan Anderman bought or sold stock recently?
- The most recent open-market purchase was on April 7, 2025: bought 20,000 shares of Compass Therapeutics, Inc. (CMPX) for $30.8K at an average of $1.54.
- How do I get alerts when Jonathan Anderman files?
- Follow Jonathan Anderman on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Jonathan Anderman (SEC CIK 0002032625). Totals count each trade once, skipping amendments whose original is on file, from Aug 9, 2024 on. View on SEC EDGAR · Get this as JSON